Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6255655 | Surgery | 2014 | 10 Pages |
Abstract
Only half of older patients with locoregional pancreatic cancer receive any treatment, and fewer than one quarter of treated patients receive multimodality therapy. Nearly all patients receiving chemotherapy as the initial treatment modality did not undergo resection, whereas half of those undergoing resection first received chemotherapy. When multimodality therapy is used, the vast majority of patients had chemotherapy in the adjuvant setting with a similar survival, regardless of approach.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Abhishek D. MD, MS, Gabriela M. MD, MS, Nina P. MD, Kristin M. PhD, Taylor S. MD, PhD,